Page 133 - Cascade_Biocatalysis_Integrating_Stereoselective_and_Environmentally_Friendly_Reactions
P. 133

5.3 Artificial Cascade Reactions Involving P450s  109

               The (S)-enantiomer was predominantly hydroxylated to the diastereoisomer
               threo-12,13-dihydroxymyristic acid (80% (12R,13R)-12,13-dihydroxymyristic acid
               and 20% (12R,13S)-12,13-dihydroxymyristic acid). When (R)-13-hydroxymyristic
               acid was used as substrate in a similar reaction system, mainly erythro-12,13-
               dihydroxymyrisitic acid (85% (12S,13R)-12,13-dihydroxymyristic acid and 15%
               (12R,13R)-12,13-dihydroxymyristic acid) was generated (Scheme 5.19) [82].

                                                          OH                     O
                                                                                   OH
                                       O                    OH
                                         OH             (12S,13S)-12,13-Dihydroxymyristic acid, 80%
                  OH                                      OH                     O
                   (R)-12-Hydroxymyristic acid
                                                                                   OH
                                                            OH
                                                        (12S,13R)-12,13-Dihydroxymyristic acid, 20%

                                                          OH                     O
                                                                                   OH
                                       O
                                                            OH
                                         OH             (12R,13R)-12,13-Dihydroxymyristic acid, 80%
                  OH                                      OH                     O
                     (S)-12-Hydroxymyristic acid
                                                                                   OH
                                                            OH
                                                        (12R,13S)-12,13-Dihydroxymyristic acid, 20%
                                                          OH                     O
                                                                                   OH
                OH                     O                    OH
                                                        (12S,13R)-12,13-Dihydroxymyristic acid, 85%
                                         OH
                                                          OH                     O
                   (R)-13-Hydroxymyristic acid
                                                                                   OH
                                                            OH
                                                        (12R,13R)-12,13-Dihydroxymyristic acid, 15%

               Scheme 5.19 Regio- and stereoselective dihydroxymyristic acid synthesis using P450 BM3.
               G-6P-DH was used for cofactor regeneration (not shown).
                A similar multi-enzyme system consisting of the F87V mutant of P450 BM3
               and G-6P-DH was applied for the preparation of 14(S),15(R)-epoxyeicosatrienoic
               acid starting with the substrate arachidonic acid. Both reactions were run on
                                                                      +
               a preparative scale (∼4 l reaction volume) containing 0.1 mmol NADP , 2 mmol
               glucose-6-phosphate, 1144 U G-6P-DH, 1.64 mmol (500 mg) arachidonic acid,
               and 600 units of P450 BM3 (F87V). After product isolation and esterification,
               249 mg of methyl 14(S),15(R)-epoxyeicosatrienoic acid (45% yield after 15 min,
   128   129   130   131   132   133   134   135   136   137   138